‘Cultural sniffiness’ over profit is hurting NHS drug trials
Some NHS staff need to “get over cultural sniffiness” about profit motives to work with pharmaceutical and tech companies to reverse the steep drop in UK clinical trials, shadow health secretary Wes Streeting has said.
In an interview with the Financial Times, Streeting laid out a plan to improve patient outcomes by putting clinical research back at the heart of the health service, ahead of the release of a government-commissioned report into the decline in trials.
This story originally appeared on: Financial Times - Author:Hannah Kuchler
